Sleep Disorders  >>  sodium oxybate  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sodium oxybate / Generic mfg.
NCT02063217: Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction

Completed
N/A
36
US
Sodium Oxybate, Xyrem, Sleep deprivation
Washington University School of Medicine, National Institutes of Health (NIH), National Institute on Aging (NIA)
Amyloid-beta
07/16
07/16
NCT00244465: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

Completed
N/A
750
Europe
UCB Pharma
Narcolepsy
09/16
09/16

Download Options